ArticleScientific reports2026
The mechanism of indigo naturalis and its active ingredients against ulcerative colitis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Indigo Naturalis (IN), utilized for thousands of years in China, is known for its effects in clearing heat, removing toxins, and alleviating diarrhea. Studies indicate that IN possesses anti-ulcerative colitis (UC) effects. However, the molecular processes that explain its therapeutic outcomes are still not fully understood. This study was to clarify the mechanism of IN against UC using both in vitro and vivo research methods. RAW264.7 cells were activated by lipopolysaccharide (LPS) (1 µg/mL) to found an inflammatory model; MTT and NO test was conducted to examine the influence of IN, indigo, indirubin, isatin, and MIX (indigo, indirubin, and isatin) on cell viability and anti-inflammatory activity. Inflammatory cytokines expression was evaluated with ELISA. Western Blotting was employed to analyze the MAPK, STAT3, and NF-κB pathways. UC model was generated by 2.5% DSS in C57BL/6 mice. Disease activity index (DAI) scoring , myeloperoxidase (MPO), and H&E staining are all for mice status. We demonstrated that IN, indirubin, and isatin can all regulate the expression of inflammatory cytokines. NF-κB, STAT3, and MAPK pathways was closely associated with IN, whereas indirubin acted to block the activation of both the NF-κB and STAT3 pathways. Contrastingly, the isatin mechanism of action was tightly connected with the regulation of the NF-κB and MAPK pathways. Additionally, MIX inhibited the activation of STAT3 pathway while suppressing the level of p-P38 expression in the MAPK pathway. MIX can enhance multiple indicators and conditions in UC mice. The active ingredients in IN (indigo, indirubin, and isatin, MIX) can significantly improve the condition of UC mice. MIX exerts anti-inflammatory effects by inhibiting the activation of the STAT3 pathway and expression of p-P38 in the MAPK pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.